The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,001–9,100 of 31,469
The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome
Topal, E., Çıkım, A. S., Çıkım, K., Temel, İ., & Оздемир, Р. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606050-00007 · Cited by 40
Díaz‐Rúa, R., Keijer, J., Caimari, A., van Schothorst, E. M., Palou, A., & Oliver, P. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.013 · Cited by 41
Tibana, R. A., Teixeira, T. G., de Farias, D. L., Silva, A. D. O., Madrid, B., Vieira, A., Franz, C. B., Bálsamo, S., Júnior, T. P. D. S., & Prestes, J. (2012) · Einstein (São Paulo) · doi:10.1590/s1679-45082012000300013 · Cited by 40
Canoy, D., Barber, T. M., Pouta, A., Hartikainen, A. L., McCarthy, M. I., Franks, S., Järvelin, M., Tapanainen, J. S., Ruokonen, A., Huhtaniemi, I. T., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1046 · Cited by 40
The incretin effect in K orean subjects with normal glucose tolerance or type 2 diabetes
Oh, T. J., Kim, M. Y., Shin, J. Y., Lee, J. C., Kim, S., Park, K. S., & Cho, Y. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12167 · Cited by 41
Lam, K. D., Bacchetti, P., Abbasi, F., Ayala, C. E., Loeb, S. M., Shah, V., Wen, M., Reaven, G. M., Maher, J. J., & Khalili, M. (2010) · Hepatology · doi:10.1002/hep.23670 · Cited by 40
Prüller, F., Raggam, R. B., Posch, V., Almer, G., Truschnig-Wilders, M., Horejsi, R., Möller, R., Weghuber, D., Ille, R., Schnedl, W. J., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.035 · Cited by 40
Xu, L., Jiang, C. Q., Lam, T. H., Cheng, K. K., Yue, X. J., Lin, J. M., Zhang, W. S., & Thomas, G. N. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.004 · Cited by 40
Kim, G., Jo, K., Kim, K. J., Lee, Y., Han, E., Yoon, H.-J., Wang, H. J., Kang, E. S., & Yun, M. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0310-4 · Cited by 40
Yamaoka‐Tojo, M., Tojo, T., Wakaume, K., Kameda, R., Nemoto, S., Takahira, N., Masuda, T., & Izumi, T. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-3 · Cited by 40
Millar, S., Perry, I. J., & Phillips, C. M. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0069-5 · Cited by 40
Yeşilada, E., Şahin, İ., Özcan, H., Yıldırım, İ. H., Yoloğlu, S., & Taşkapan, Ç. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02117 · Cited by 40
Friedman, A. N., Marrero, D. G., Ma, Y., Ackermann, R. T., Narayan, K. M. V., Barrett-Connor, E. L., Watson, K. E., Knowler, W. C., & Horton, E. S. (2008) · Diabetes Care · doi:10.2337/dc08-0148 · Cited by 40
Lima, V. B. D. S., Sampaio, F. A., Bezerra, D. L. C., et al. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000900006 · Cited by 40
Bharadwaj, M. S., Tyrrell, D. J., Leng, I., Demons, J. L., Lyles, M. F., Carr, J. J., Nicklas, B. J., & Molina, A. J. A. (2015) · BMC Obesity · doi:10.1186/s40608-015-0070-4 · Cited by 41
Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline
Sung, K., Kim, B., Cho, Y.-K., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-84 · Cited by 40
Shiraev, T. P., Chen, H., & Morris, M. J. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01877.x · Cited by 42
Nilsson, G., Hedberg, P., Jonason, T., Lönnberg, I., Tenerz, Å., Forberg, R., & Öhrvik, J. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.01.018 · Cited by 40
The Association Between Serum Albumin Levels and Metabolic Syndrome in a Rural Population of Korea
Cho, H. M., Kim, H. C., Lee, J. M., Oh, S. M., Choi, D. P., & Suh, I. (2012) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2012.45.2.98 · Cited by 40
Metabolic Syndrome Increases Carotid Artery Stiffness: the Northern Manhattan Study
Della‐Morte, D., Gardener, H. E., Denaro, F., Boden-Albala, B. M., Elkind, M. S. V., Paik, M. C., Sacco, R. L., & Rundek, T. (2010) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00421.x · Cited by 39
Llaneza, P., González, C., Fernández-Iñarrea, J., Alonso, A., Díaz-Fernández, M. J., Arnott, I., & Ferrer-Barriendos, J. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ba56fa · Cited by 40
Association of serum lipoprotein ratios with insulin resistance in type 2 diabetes mellitus.
Tangvarasittichai, S., Poonsub, P., & Tangvarasittichai, O. (2010) · PubMed · Cited by 40
Cooper, J. N., Columbus, M. L., Shields, K. J., Asubonteng, J. O., Meyer, M. L., Sutton‐Tyrrell, K., Goodpaster, B. H., DeLany, J. P., Jakicic, J. M., & Barinas‐Mitchell, E. (2012) · Metabolism · doi:10.1016/j.metabol.2012.04.012 · Cited by 42
Huang, F., Yang, Z., Xu, B., Bi, Y., Xu, M., Xu, Y. H., Lu, J., Liu, Y., Dai, M., Zhou, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054628 · Cited by 40
Yajnik, C. S., Joglekar, C. V., Pandit, A. N., Bavdekar, A., Bapat, S. A., Bhave, S. A., Leary, S. D., & Fall, C. H. D. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2090 · Cited by 40
Gilbert, R. E., Thai, K., Advani, S. L., Cummins, C. L., Kepecs, D. M., Schroer, S. A., Woo, M., & Zhang, Y. (2015) · Diabetologia · doi:10.1007/s00125-014-3485-4 · Cited by 40
Krishnaveni, G. V., Veena, S. R., Jones, A., Srinivasan, K., Osmond, C., Karat, S. C., Kurpad, A. V., & Fall, C. H. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3239 · Cited by 41
Li, M., Reynolds, C. M., Sloboda, D. M., Gray, C. L., & Vickers, M. H. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.015 · Cited by 39
Ellakwa, H., Sanad, Z. F., Hamza, H. A., Emara, A. M., & Elsayed, M. A. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.09.008 · Cited by 40
Abdominal Obesity and Insulin Resistance in People Exposed to Moderate-to-High Levels of Dioxin
Chang, J.-W., Chen, H., Su, H.-J. J., & Lee, C.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145818 · Cited by 40
Qu, C., Zhou, X., Yang, G., Li, L., Liu, H., & Liang, Z. (2016) · Cytokine · doi:10.1016/j.cyto.2015.12.024 · Cited by 40
Short-term moderate sleep restriction decreases insulin sensitivity in young healthy adults
Wang, X., Greer, J., Porter, R. R., Kaur, K., & Youngstedt, S. D. (2016) · Sleep Health · doi:10.1016/j.sleh.2015.11.004 · Cited by 42
El‐Shal, A. S., Zidan, H. E., Rashad, N. M., Abdelaziz, A. M., & Harira, M. M. (2015) · IUBMB Life · doi:10.1002/iub.1457 · Cited by 39
Yang, R., Ma, X., Dou, J., Wang, F., Luo, Y., Li, D., Zhu, J., Bao, Y., & Jia, W. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31828aa32d · Cited by 40
Garanty‐Bogacka, B., Syrenicz, M., Rać, M. E., Krupa, B., Czaja‐Bulsa, G., Walczak, M., Sowińska-Przepiera, E., & Syrenicz, A. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0016 · Cited by 41
Fukushima, Y., Kurose, S., Shinno, H., Thu, H. C. T., Takao, N., Tsutsumi, H., & Kimura, Y. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.147 · Cited by 42
Ghaffarzad, A., Amani, R., Sadaghiani, M. M., Darabi, M., & Cheraghian, B. (2016) · PubMed Central · doi:10.22074/ijfs.2016.4765 · Cited by 39
Association between Metabolite Profiles, Metabolic Syndrome and Obesity Status
Allam‐Ndoul, B., Guénard, F., Garneau, V., Cormier, H., Barbier, O., Përusse, L., & Vohl, M. (2016) · Nutrients · doi:10.3390/nu8060324 · Cited by 40
The Association between Central Adiposity and Autonomic Dysfunction in Obesity
Yaylalı, G. F., Yaylalı, Y. T., Erdoğan, Ç., Can, B., Şenol, H., Topcu, B. G., & Topsakal, Ş. (2016) · Medical Principles and Practice · doi:10.1159/000446915 · Cited by 42
Metabolic and Endocrine Characteristics of Indian Women with Polycystic Ovary Syndrome.
Kumar, A. N., Naidu, J. N., Satyanarayana, U., Ramalingam, K., & Anitha, M. (2016) · PubMed Central · doi:10.22074/ijfs.2016.4764 · Cited by 40
Reyes-Muñoz, E., Ortega-González, C., Martínez-Cruz, N., Arce-Sánchez, L., Estrada‐Gutiérrez, G., Morán, C., Sánchez-Serrano, A. P., Higareda-Sánchez, R., & la Jara-Díaz, J. F. D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012107 · Cited by 41
Stättermayer, A. F., Traussnigg, S., Aigner, E. S., Kienbacher, C., Huber-Schönauer, U., Steindl‐Munda, P., Stadlmayr, A., Wrba, F., Trauner, M. A., Datz, C., et al. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.08.006 · Cited by 40
Senaphan, K., Sangartit, W., Pakdeechote, P., Kukongviriyapan, V., Pannangpetch, P., Thawornchinsombut, S., Greenwald, S. E., & Kukongviriyapan, U. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1311-0 · Cited by 40
Joyce, K. E., Biggs, M. L., Djoussé, L., Ix, J. H., Kizer, J. R., Siscovick, D. S., Shores, M. M., Matsumoto, A. M., & Mukamal, K. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2623 · Cited by 40
Vine, D., Wang, Y., Jetha, M., Ball, G., & Proctor, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2854 · Cited by 40
Natsag, J., Erlandson, K. M., Sellmeyer, D. E., Haberlen, S., Margolick, J. B., Jacobson, L. P., Palella, F. J., Koletar, S. L., Lake, J. E., Post, W. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169184 · Cited by 40
Plasma L -carnitine levels of obese and non-obese polycystic ovary syndrome patients
Çelik, F., Köse, M., Yılmazer, M., Köken, G., Arıöz, D. T., & Pektas, M. K. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2016.1264375 · Cited by 40
Khan, R. A., Kapur, P., Jain, A., Farah, F., & Bhandari, U. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s124621 · Cited by 40
The triglyceride and glucose index is useful for recognising insulin resistance in children
Rodríguez‐Morán, M., Simental‐Mendía, L., & Guerrero‐Romero, F. (2017) · Acta Paediatrica · doi:10.1111/apa.13789 · Cited by 40
Lucero, D., Miksztowicz, V., Gualano, G., Longo, C., Landeira, G., Álvarez, E., Zago, V., Brites, F. D., Berg, G. A., Fassio, E., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.006 · Cited by 38
Association of leptin and insulin resistance in PCOS: A case-controlled study
Jahromi, B. N., Dabaghmanesh, M. H., Parsanezhad, M. E., & Fatehpoor, F. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.7.423 · Cited by 40
Elwahab, A. H. A., Ramadan, B. K., Schaalan, M. F., & Tolba, A. M. A. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480649 · Cited by 40
Sakpal, M., Satsangi, S., Mehta, M., et al. (2017) · JGH Open · doi:10.1002/jgh3.12010 · Cited by 40
Moretti, C., Guccione, L., Giacinto, P. D., Simonelli, I., Exacoustós, C., Toscano, V., Motta, C., Leo, V. D., Petraglia, F., & Lenzi, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01186 · Cited by 39
Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women
Kabat, G. C., Kim, M., Stefanick, M. L., Ho, G. Y. F., Lane, D. S., Odegaard, A., Simon, M. S., Bea, J. W., Luo, J., Wassertheil-Smoller, S. W., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31345 · Cited by 45
Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis
Silva, T. E., Silva, M. C., Corrêa, C. G., Denardin, G., Alencar, M. L. A., Coelho, M. S. P. H., Wildner, L. M., Bazzo, M. L., González‐Chica, D. A., Dantas-Corrêa, E. B., et al. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8660 · Cited by 41
Hu, D., Remash, D., Russell, R., Greenaway, T. M., Rattigan, S., Squibb, K. A., Jones, G., Premilovac, D., Richards, S. M., & Keske, M. A. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007074 · Cited by 41
Abdellatif, R., Heeba, G. H., Taye, A., & Khalifa, M. M. A. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1497-1 · Cited by 40
Gut hormone release after gastric bypass depends on the length of the biliopancreatic limb
Patrício, B. G., Morais, T., Guimarães, M., Veedfald, S., Hartmann, B., Hilsted, L., Holst, J. J., Nora, M. C., & Monteiro, M. P. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0117-y · Cited by 40
Wolf, R. M., Jaffe, A. E., Steele, K. E., Schweitzer, M., Magnuson, T. H., Wolfe, A., & Wong, G. W. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02245 · Cited by 41
Arendt, B. M., Teterina, A. A., Pettinelli, P., Comelli, E. M., David, W. L., Fung, S. K., McGilvray, I. D., Fischer, S. E., & Allard, J. P. (2018) · Nutrition · doi:10.1016/j.nut.2018.12.001 · Cited by 40
Xin, Y., Wang, Y., Chi, J., Zhu, X., Zhao, H., Zhao, S., & Wang, Y. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s186505 · Cited by 40
Blond, M. B., Rosenkilde, M., Gram, A. S., Tindborg, M., Christensen, A. N., Quist, J. S., & Stallknecht, B. M. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100036 · Cited by 43
Manzoor, S., Ganie, M. A., Amin, S., Shah, Z. A., Bhat, I. A., Yousuf, S. D., Jeelani, H., Kawa, I. A., Fatima, Q., & Rashid, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-46644-4 · Cited by 40
Cristi‐Montero, C., Courel‐Ibáñez, J., Ortega, F. B., Castro‐Piñero, J., Santaliestra-Pasías, A. M., Polito, A., Vanhelst, J., Marcos, A., Moreno, L. M., & Ruiz, J. R. (2019) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2019.08.003 · Cited by 41
Izumida, T., Nakamura, Y., Hino, Y., & Ishikawa, S. (2020) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.49528 · Cited by 37
Mitchell, S. M., Milan, A. M., Mitchell, C. J., Gillies, N. A., D’Souza, R. F., Zeng, N., Ramzan, F., Sharma, P., Knowles, S. O., Roy, N. C., et al. (2019) · Nutrients · doi:10.3390/nu11092207 · Cited by 40
Pradas, I., Rovira‐Llopis, S., Naudí, A., Bañuls, C., Rocha, M., Hernández‐Mijares, A., Pamplona, R., Víctor, V. M., & Jové, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52263-w · Cited by 41
Joris, P. J., Draijer, R., Fuchs, D., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.032 · Cited by 40
Roy, S. S., yuzefpolskaya, M., Nandakumar, R., Colombo, P. C., & Demmer, R. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227482 · Cited by 40
El-Nasr, N. M. E. A., Saleh, D. O., Mahmoud, S. S., Nofal, S. M., Abdelsalam, R. M., Safar, M. M., & El-Abhar, H. S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173010 · Cited by 40
Circulating levels of C1q/TNF‐α‐related protein 6 (CTRP6) in polycystic ovary syndrome
Sadeghi, A., Fadaei, R., Moradi, N., Fouani, F. Z., Roozbehkia, M., Zandieh, Z., Ansaripour, S., Vatannejad, A., & Doustimotlagh, A. H. (2020) · IUBMB Life · doi:10.1002/iub.2272 · Cited by 41
Elman, I., Howard, M., Borodovsky, J. T., Mysels, D. J., Rott, D., Borsook, D., & Albanese, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-62556-0 · Cited by 42
Karras, S. Ν., Koufakis, T., Adamidou, L., Antonopoulou, V., Karalazou, P., Thisiadou, K., Mitrofanova, E., Mulrooney, H. M., Petróczi, A., Zebekakis, P. E., et al. (2020) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2020.1760218 · Cited by 40
Choromańska, B., Myśliwiec, P., Łuba, M., et al. (2020) · Antioxidants · doi:10.3390/antiox9050376 · Cited by 40
Fahlbusch, P., Knebel, B., Hörbelt, T., Barbosa, D. M., Nikolic, A., Jacob, S., Al‐Hasani, H., de Velde, F. V., Nieuwenhove, Y. V., Müller‐Wieland, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114144 · Cited by 40
Sex-Specific Associations between Gut Prevotellaceae and Host Genetics on Adiposity
Cuevas‐Sierra, A., Riezu‐Boj, J. I., Guruceaga, E., Milagro, F. I., & Martínez, J. A. (2020) · Microorganisms · doi:10.3390/microorganisms8060938 · Cited by 41
Ahmed, L. A., Salem, M. B., el-Din, S. H. S., El-Lakkany, N. M., Okasha, H., Nasr, S. M., Hammam, O. A., Botros, S. S., & Saleh, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173461 · Cited by 40
Clarembeau, F., Bale, G., & Lanthier, N. (2020) · Clinical Science · doi:10.1042/cs20200022 · Cited by 40
Delgado, A. S. H., Roffe-Vazquez, D. N., González-Gil, A. M., Villarreal-Calderón, J. R., Tamez‐Rivera, O., Rodríguez-Gutiérrez, N. A., Castillo, E. C., Silva‐Platas, C., García‐Rivas, G., & Elizondo‐Montemayor, L. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1949415 · Cited by 41
Reduced Olfactory Bulb Volume in Obesity and Its Relation to Metabolic Health Status
Poessel, M., Breuer, N., Joshi, A., Pampel, A., Villringer, A., Hummel, T. R., & Horstmann, A. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.586998 · Cited by 40
Association between Serum Vitamin B12 and Global DNA Methylation in Colorectal Cancer Patients
Boughanem, H., Hernández‐Alonso, P., Tinahones, A., Babió, N., Salas‐Salvadó, J., Tinahones, F. J., & Macías‐González, M. (2020) · Nutrients · doi:10.3390/nu12113567 · Cited by 40
Sex differences in brown adipose tissue activity and cold-induced thermogenesis
Herz, C. T., Kulterer, O. C., Prager, M., Marculescu, R., Langer, F. B., Prager, G., Kautzky‐Willer, A., Haug, A. R., & Kiefer, F. W. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111365 · Cited by 40
Pedersen, J. S., Rygg, M. O., Serizawa, R., Kristiansen, V. B., Albrechtsen, N. J. W., Gluud, L. L., Madsbad, S., & Bendtsen, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173783 · Cited by 42
Salton, N., Kern, S., Interator, H., Lopez, A., Moran‐Lev, H., Lebenthal, Y., & Brener, A. (2021) · Childhood Obesity · doi:10.1089/chi.2021.0157 · Cited by 45
Short-Term Overeating Induces Insulin Resistance in Fat Cells in Lean Human Subjects
Danielsson, A., Fagerholm, S., Öst, A., Franck, N., Kjølhede, P., Nyström, F. H., & Strålfors, P. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00037 · Cited by 39
Wang, Z., Hui, X., Huang, X., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01180-7 · Cited by 40
Depot-Specific Expression of Lipolytic Genes in Human Adipose Tissues
Nagashima, S., Yagyu, H., Takahashi, N., Kurashina, T., Takahashi, M., Tsuchita, T., Tazoe, F., Wang, X. L., Tumenbayar, B., Sato, N. S., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.6478 · Cited by 40
Imajo, K., Fujita, K., Yoneda, M., Shinohara, Y., Suzuki, K., Mawatari, H., Takahashi, J., Nozaki, Y., Sumida, Y., Kirikoshi, H., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.00976.x · Cited by 40
de Sousa, G., Brodoswki, C., Kleber, M., Wunsch, R., & Reinehr, T. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03710.x · Cited by 40
Pepene, C. E. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04171.x · Cited by 40
Lin, T.-C., Yen, J.-M., Gong, K.-B., Kuo, T., Ku, D.-C., Liang, S., & Wu, M. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-36 · Cited by 42
Pranprawit, A., Wolber, F. M., Heyes, J. A., et al. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6240 · Cited by 40
Goto, M., Goto, A., Morita, A., Deura, K., Sasaki, S., Aiba, N., Shimbo, T., Terauchi, Y., Miyachi, M., Noda, M., et al. (2013) · Obesity · doi:10.1002/oby.20553 · Cited by 42
Serum chromium does not predict glucose tolerance in late pregnancy
Gunton, J. E., Hams, G., Hitchman, R., & McElduff, A. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.1.99 · Cited by 41
Effect of Walking with a Pedometer on Serum Lipid and Adiponectin Levels in Japanese Middle-aged Men
Kobayashi, J., Murase, Y., Asano, A., Nohara, A., Kawashiri, M., Inazu, A., Yamagishi, M., & Mabuchi, H. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.197 · Cited by 41
Koh, H., Hayashi, T., Satō, K., Harita, N., Maeda, I., Nishizawà, Y., Endo, G., Fujimoto, W. Y., Boyko, E. J., & Hikita, Y. (2011) · Hypertension Research · doi:10.1038/hr.2010.271 · Cited by 40
Impact of Sitagliptin on Markers of β-cell Function: A Meta-Analysis
Riche, D. M., East, H. E., & Riche, K. D. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31818eb721 · Cited by 40
The Singapore Impaired Glucose Tolerance Follow-Up Study
Wong, M.-S., Gu, K., Heng, D., Chew, S., Chew, L. S., & Tai, E. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3024 · Cited by 40
Wang, Z. L., Xia, B., Shrestha, U. K., Jiang, L., W., C., Chen, Q., Chen, H., & Zhang, H. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345657 · Cited by 40
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
